Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG)
Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG)
M. E. P. Philippens, P. A. Robe, M. van der Meulen, T. Rozema et al.
Journal
PLoS ONE
Topics
Glioma Diagnosis and Treatment
article
Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG)
M. E. P. Philippens, P. A. Robe, M. van der Meulen, T. Rozema, D. B. P. Eekers, J. Hendrikse, F. Cialdella, C. C. B. Post, G. Wester, T. J. Snijders, J. J. C. Verhoeff, J. Vos-Westerman, F. Y. F. L. de Vos, J. Zindler, F. J. Lagerwaard, M. C. A. Kramer, A. T. J. van der Boog, A. M. de Jong, H. L. van der Weide
article en
Abstract
No abstract available for this paper.
Publication Tag
PLoS ONEVol. 21(2)
Institutions
University Medical Center Groningen (NL), Maastricht University Medical Centre (NL), Medisch Spectrum Twente (NL), University Medical Center Utrecht (NL), Medisch Centrum Haaglanden (NL), Instituut Verbeeten (NL), Radiotherapiegroep (NL), Isala (NL), Amsterdam University Medical Centers (NL), Maastro Clinic (NL)